A heterobivalent ligand for the adenosine A2A-dopamine D2 receptor heteromer

Data de publicació

2026-01-23T15:51:16Z

2026-01-23T15:51:16Z

2022-01-04

2026-01-23T15:51:16Z

Resum

A G protein-coupled receptor heteromer that fulfills the established criteria for its existence in vivo is the complex between adenosine A2A (A2AR) and dopamine D2 (D2R) receptors. Here, we have designed and synthesized heterobivalent ligands for the A2AR−D2R heteromer with various spacer lengths. The indispensable simultaneous binding of these ligands to the two different orthosteric sites of the heteromer has been evaluated by radioligand competition-binding assays in the absence and presence of specific peptides that disrupt the formation of the heteromer, label-free dynamic mass redistribution assays in living cells, and molecular dynamic simulations. This combination of techniques has permitted us to identify compound 26 [KDB1 (A2AR) = 2.1 nM, KDB1 (D2R) = 0.13 nM], with a spacer length of 43-atoms, as a true bivalent ligand that simultaneously binds to the two different orthosteric sites. Moreover, bioluminescence resonance energy transfer experiments indicate that 26 favors the stabilization of the A2AR−D2R heteromer.

Tipus de document

Article


Versió acceptada

Llengua

Anglès

Publicat per

American Chemical Society

Documents relacionats

Versió postprint del document publicat a: https://doi.org/10.1021/acs.jmedchem.1c01763

Journal of Medicinal Chemistry, 2022, vol. 65, num.1, p. 616-632

https://doi.org/10.1021/acs.jmedchem.1c01763

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

(c) American Chemical Society, 2022

Aquest element apareix en la col·lecció o col·leccions següent(s)